LEADER 02396nam  2200577   450 
001 9910787562603321
005 20230803030902.0
010   $a1-60805-496-9
035   $a(CKB)2670000000400495
035   $a(EBL)1310817
035   $a(OCoLC)854975258
035   $a(SSID)ssj0001152099
035   $a(PQKBManifestationID)11641284
035   $a(PQKBTitleCode)TC0001152099
035   $a(PQKBWorkID)11145152
035   $a(PQKB)10603857
035   $a(Au-PeEL)EBL1310817
035   $a(CaPaEBR)ebr10756232
035   $a(MiAaPQ)EBC1310817
035   $a(EXLCZ)992670000000400495
100   $a20111102d2013      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aAdvances in anticancer agents in medicinal chemistry$hVolume 2 /$fedited by Michelle Prudhomme
210  1$aSharjah :$cBentham Science Publishers,$d[2013]
210  4$dİ2013
215   $a1 online resource (495 p.)
225 0 $aAdvances in anticancer agents in medicinal chemistry ;$v2
300   $aDescription based upon print version of record.
311   $a1-60805-715-1 
320   $aIncludes bibliographical references and index.
327   $aCover; Title; EUL; Contents; Foreword; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Chapter 09; Chapter 10; Index
330   $aAdvances in Anticancer Agents in Medicinal Chemistry is an exciting eBook series comprising a selection of updated articles previously published in the peer-reviewed journal Anti-Cancer Agents in Medicinal Chemistry. The second Volume of this eBook series gathers updated reviews on several classes of molecules exhibiting anticarcinogenic potential as well as some important targets for the development of novel anticancer drugs.
410  0$aAdvances in Anticancer Agents in Medicinal Chemistry
606   $aAntineoplastic agents
606   $aPharmaceutical chemistry
615  0$aAntineoplastic agents.
615  0$aPharmaceutical chemistry.
676   $a616.99
676   $a616.994061
701   $aPrudhomme$b Michelle$01571970
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910787562603321
996   $aAdvances in anticancer agents in medicinal chemistry$93846551
997   $aUNINA